RU2302240C2 - Производные карбаматов для предотвращения или лечения психотических нарушений - Google Patents

Производные карбаматов для предотвращения или лечения психотических нарушений Download PDF

Info

Publication number
RU2302240C2
RU2302240C2 RU2003128983/14A RU2003128983A RU2302240C2 RU 2302240 C2 RU2302240 C2 RU 2302240C2 RU 2003128983/14 A RU2003128983/14 A RU 2003128983/14A RU 2003128983 A RU2003128983 A RU 2003128983A RU 2302240 C2 RU2302240 C2 RU 2302240C2
Authority
RU
Russia
Prior art keywords
formula
group
disorder
enantiomer
psychotic
Prior art date
Application number
RU2003128983/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2003128983A (ru
Inventor
Карлос Р. ПЛАТА-САЛАМАН (US)
Карлос Р. Плата-Саламан
Бою ЗАО (US)
Бою ЗАО
Рой Э. ТУАЙМЭН (US)
Рой Э. ТУАЙМЭН
Original Assignee
Орто-Макнейл Фармасьютикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орто-Макнейл Фармасьютикал, Инк. filed Critical Орто-Макнейл Фармасьютикал, Инк.
Publication of RU2003128983A publication Critical patent/RU2003128983A/ru
Application granted granted Critical
Publication of RU2302240C2 publication Critical patent/RU2302240C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2003128983/14A 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений RU2302240C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US60/271,889 2001-02-27
US10/081,761 2002-02-21
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
RU2003128983A RU2003128983A (ru) 2005-03-10
RU2302240C2 true RU2302240C2 (ru) 2007-07-10

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003128983/14A RU2302240C2 (ru) 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений

Country Status (25)

Country Link
US (1) US6541513B2 (enExample)
EP (1) EP1401424B1 (enExample)
JP (1) JP4276841B2 (enExample)
KR (1) KR100886578B1 (enExample)
CN (1) CN1262271C (enExample)
AR (1) AR032876A1 (enExample)
AT (1) ATE346597T1 (enExample)
AU (1) AU2002242296B2 (enExample)
BR (1) BR0207829A (enExample)
CA (1) CA2439480C (enExample)
CZ (1) CZ302412B6 (enExample)
DE (1) DE60216457T2 (enExample)
DK (1) DK1401424T3 (enExample)
ES (1) ES2275844T3 (enExample)
HU (1) HUP0303342A3 (enExample)
IL (2) IL157588A0 (enExample)
MX (1) MXPA03007722A (enExample)
NO (1) NO20033801L (enExample)
NZ (1) NZ527991A (enExample)
PL (1) PL365021A1 (enExample)
PT (1) PT1401424E (enExample)
RS (1) RS51056B (enExample)
RU (1) RU2302240C2 (enExample)
TW (1) TWI251486B (enExample)
WO (1) WO2002067927A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067925A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
CA2439286A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
DE60232796D1 (de) 2001-07-16 2009-08-13 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
WO2008054984A1 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
КАПЛАН Г. и др. Клиническая психиатрия. - М.: ГЭОТАР МЕДИЦИНА, 1994, с.124. VOVIN R.Ia. et al. Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987; 87(9):1396-400. *
Психиатрия. / Под ред. Р.Шейдера. - М.: Практика, 1998, с.420. *

Also Published As

Publication number Publication date
RU2003128983A (ru) 2005-03-10
EP1401424A1 (en) 2004-03-31
IL157588A0 (en) 2004-03-28
CA2439480A1 (en) 2002-09-06
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
WO2002067927A1 (en) 2002-09-06
NO20033801D0 (no) 2003-08-26
JP4276841B2 (ja) 2009-06-10
AR032876A1 (es) 2003-11-26
DE60216457T2 (de) 2007-09-20
NZ527991A (en) 2005-04-29
EP1401424B1 (en) 2006-11-29
ES2275844T3 (es) 2007-06-16
PT1401424E (pt) 2007-02-28
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
HUP0303342A3 (en) 2012-07-30
NO20033801L (no) 2003-10-22
CN1505507A (zh) 2004-06-16
KR100886578B1 (ko) 2009-03-05
KR20030076713A (ko) 2003-09-26
ATE346597T1 (de) 2006-12-15
PL365021A1 (en) 2004-12-27
CN1262271C (zh) 2006-07-05
IL157588A (en) 2009-12-24
HUP0303342A2 (hu) 2004-01-28
TWI251486B (en) 2006-03-21
BR0207829A (pt) 2004-06-22
CZ20032297A3 (cs) 2004-06-16
RS67503A (sr) 2006-12-15
US20020165272A1 (en) 2002-11-07
DK1401424T3 (da) 2007-02-26
US6541513B2 (en) 2003-04-01
MXPA03007722A (es) 2004-11-12
RS51056B (sr) 2010-10-31
CA2439480C (en) 2011-04-26

Similar Documents

Publication Publication Date Title
KR101335941B1 (ko) 수면-각성 장애의 치료
KR20120080656A (ko) 주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
JP2008542378A (ja) 精神病性障害を管理する方法および組成物
JP2010531879A (ja) 水素化ピリド［４，３−ｂ］インドールに基づく抗不安作用を示す薬物、その薬理学的な化合物および適用方法
RU2302240C2 (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
JP2005523334A (ja) ストレス関連障害を含む機能的身体障害の予防および処置
KR20030074847A (ko) 거동 장애 예방 또는 치료용 카바메이트 화합물
TW202327572A (zh) 用於輔助心理治療的ｒ－ｍｄｍａ和ｓ－ｍｄｍａ
US20250122164A1 (en) N,n-dimethylamphetamine analogs for treating brain disorders
HK1247847A1 (zh) 四氢-N，N-二甲基-2，2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途
RU2300372C2 (ru) Карбаматы для применения для предотвращения или лечения биполярного расстройства
KR20080089414A (ko) 우울증 치료를 위한 벤조-융합된 헤테로사이클 설파미드유도체의 용도
RS51790B (sr) Upotreba derivata benzo-kondenzovanih heterocikličkih sulfamida za lečenje manije i bipolarnog poremećaja
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
EA015566B1 (ru) Применение пептидного соединения для добавочной терапии к антагонисту дофамина и фармацевтическая композиция, его содержащая
CN101272776B (zh) 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途
DE60210960T2 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
US20060167026A1 (en) Antipsychotic molecular-targeting epithelial growth factor receptor
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
WO2021234642A1 (en) The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia
Witkin et al. Protection Against Cocaine Toxicity in mice by the DopamineD3/D2 Agonist (+)-PD-128,907

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20190207

PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20190506